Dr Kalemkerian on Unmet Needs With the Use of Chemoimmunotherapy in ES-SCLC
August 24th 2023Gregory Peter Kalemkerian, MD, discusses the unmet needs associated with the investigation of combination chemoimmunotherapy in the frontline treatment of patients with extensive-stage small cell lung cancer.
Read More